Discover Community Create You

Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Article

Accuracy of Risk Prediction Models for Breast Cancer and BRCA1/BRCA2 Mutation Carrier Probabilities in Israel.

Anticancer research - 1 Aug 2018

Kenan Efrat Schwarz, Friger Michael, Shochat-Bigon Daphna, Schayek Hagit, Bernstein-Molho Rinat, Friedman Eitan

Abstract excerpt

BACKGROUND/AIM: Several algorithms have been developed to assess the risk of predicting BRCA mutation and breast cancer (BC) risk. The aim of this study was to evaluate the accuracy of these prediction algorithms in the Israeli population. PATIENTS AND METHODS: Risk for developing breast cancer and the probability for carrying BRCA1/2 mutations using BOADICEA, BRCAPRO, IBIS, MYRIAD and PENN2 models were computed...

Read the complete abstract on PubMed

Topics

Share this publication in a Topic to start or enrich a Post.

Share to Algorithms
Share to BRCA1 Protein

Methodology Data sources Editorial policy Privacy About Contact Helena Bioinformatics

Share to BRCA2 Protein

Share to Breast Neoplasms

Share to Genetic Testing

Share to Israel

Share to Probability

Share to Risk Assessment

Source

Identifiers

PMID: 30061222
DOI: 10.21873/anticanres.12760

Genes

BRCA1
BRCA2

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 7 Sept 2026. Manifest publication-graph-cohort-2026-09-07.1.

Source receipt: pubmed, retrieved 7 Sept 2026.

Related research

Semantic proximity does not establish scientific evidence.

Research trail→

Click a neighbor to travelStep 1 · 12 closest

Accuracy of Risk Prediction Models for Breast Cancer and BRCA1/BRCA2 Mutation Carrier Probabilities in Israel.PMID 30061222Read ↗

Breast cancer risk prediction accuracy in Jewish Israeli high-risk women using the BOADICEA and IBIS risk models.Semantic proximity Read ↗

Validating the IBIS and BOADICEA Models for Predicting Breast Cancer Risk in the Iranian Population.Semantic proximity Read ↗

Breast cancer risk models: a comprehensive overview of existing models, validation, and clinical applications.Semantic proximity Read ↗

Evaluating the performance of the breast cancer genetic risk models BOADICEA, IBIS, BRCAPRO and Claus for predicting BRCA1/2 mutation carrier probabilities: a study based on 7352 families from the German Hereditary Breast and Ovarian Cancer Consortium.Semantic proximity Read ↗

Evaluation of the BOADICEA risk assessment model in women with a family history of breast cancer.Semantic proximity Read ↗

Evaluating breast cancer risk: available models to assess individual breast cancer risk and probability to be a BRCA mutation carrier.Semantic proximity Read ↗

Assessing women at high risk of breast cancer: a review of risk assessment models.Semantic proximity Read ↗

Predicting the likelihood of carrying a BRCA1 or BRCA2 mutation: validation of BOADICEA, BRCAPRO, IBIS, Myriad and the Manchester scoring system using data from UK genetics clinics.Semantic proximity Read ↗

A pivotal study on patients’ selection for BRCA1 and BRCA2 mutations by different models in Libyan breast cancer womenSemantic proximity Read ↗

Validation of the BOADICEA model for predicting the likelihood of carrying pathogenic variants in eight breast and ovarian cancer susceptibility genesSemantic proximity Read ↗

Accuracy of BRCA1/2 mutation prediction models for different ethnicities and genders: experience in a southern Chinese cohort.Semantic proximity Read ↗

The yield of targeted genotyping for the recurring mutations in BRCA1/2 in Israel.Semantic proximity Read ↗

⌁Select a neighboring publication to make it the new centre.